Atlas Trials

Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone

Clinical trial NCT02640534 · TERMINATED

Trial details

NCT number
NCT02640534
Sponsor
Swiss Cancer Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer of the ProstateProstate Cancer
Start date
2016-06-10
Primary completion
2022-07-01
Enrollment
169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.